Authors




Zach Gobst

Latest:

Why You Should Expand Your Patient Advocacy Strategy to Include Health Influencers

With radio, billboard, TV, and digital advertisements being left in the dust, additional engagement from influencer communities are more likely to be reach patients.




Kevin Connor

Latest:

Three Steps to Better Decisions

Decision makers can increase collaboration, transparency, efficiency, and effectiveness, while reducing development risks.


Signant Health

Latest:

Train, Analyze, Intervene: How a Three-Pronged Approach Improves Data Quality in Dermatology Trials

This whitepaper offers readers tips on how to improve the data quality in dermatology trials using a unique, three-pronged approach.


IMARC Research

Latest:

How to Get Data and Safety Managers on the Same Team

Every successful clinical trial must protect patients while collecting complete, accurate data that supports evaluation of the safety and effectiveness of the drug or device. Here’s a closer look at why data and safety managers are so important to a clinical trial, what can go wrong when they aren’t aligned and how to improve collaboration between them.


Andrew Snyder

Latest:

Fair Market Conundrum: Solutions for Sponsors & Sites

Breaking through the confusion around fair market value when applying the concept to study budgets.


Medable

Latest:

The Top 5 Myths About eCOAs In 2025

Webinar Date/Time: Tue, Apr 15, 2025 1:00 PM EDT


Elaine Harris

Latest:

Clinical Trials and Social Networking

There are significant challenges facing the pharmaceutical and contract research organization (CRO) industries in relation to patient recruitment of clinical trials and the need to implement new strategies to finally overcome what has been called ‘the most difficult and challenging aspect of clinical trials.’


Rani Abraham

Latest:

MENA: The Dawn of a New Era

The Middle East and North Africa region has seen a recent increase in clinical trials research.



Brian Mullin, Brand Insights Contributor, Mgr. of Clinical Project Svcs, Almac Clinical Technologies

Latest:

IRT: A Competitive Advantage to Accelerate Clinical Trials

Interactive response technology (IRT) can serve many different functions in clinical research, from patient randomization to making data-driven calculations for patient dosing.


Steve McDonald, Brand Insights Contributor, Dir. of Business Dev, Almac Clinical Technologies

Latest:

IRT: A Competitive Advantage to Accelerate Clinical Trials

Interactive response technology (IRT) can serve many different functions in clinical research, from patient randomization to making data-driven calculations for patient dosing.



Chartfield Bliss

Latest:

3 Ways CTMS Helps Manage Adaptive Trials

While adaptive trial designs have been slow to gain traction, there a many benefits to adopting this trial model.


John Benbrook

Latest:

Todos Juntos por la Salud

A MMG strategic initaitve to address disparities in clinical research participation among Hispanic and Latino communities.


Elligo

Latest:

Planning Clinical Research Studies for Successful Decentralized Trials

This podcast will discuss: • How partnering with specialized research organizations can help identify large, diverse patient populations to facilitate clinical studies designed around the patient • How advanced study planning and communication with regulators can ensure more successful execution of decentralized and hybrid clinical trials • The importance of the patient-physician dyad in implementing successful research studies


Herbert Maier-Lenz, MD

Latest:

Academic Strength in Germany

The founding of the KKSN has helped Germany increase its clinical trial output.


Dr. Satish Tadikonda

Latest:

New Technologies to Improve Clinical Information Management

Today's pharmaceutical industry faces many challenges as drug development costs continue to climb, pricing pressures mount, and new global markets gain critical importance.


Jean Pierre Wery

Latest:

Analyzing 2013 Oncology Trends to Predict 2014 Directions

When examining the frequency in use of keywords related to cancer research, some important trends emerge.


Esther Daemen, MBA, RN

Latest:

Moving From Compliance to Competency: A Harmonized Core Competency Framework for the Clinical Research Professional

Medicines development and clinical research are among the most heavily regulated activities on a global basis.


Kimberly Irvine, CIP, CIM

Latest:

Playing in the Sandbox--How Local Institutional Review Boards Can Happily Co-Exist with Central IRBs

A recent paper published in PLOS ONE addresses research institutions? willingness ?or lack thereof?to defer to central institutional review boards for multicenter clinical trials.


Rebecca Li, PhD

Latest:

Moving From Compliance to Competency: A Harmonized Core Competency Framework for the Clinical Research Professional

Medicines development and clinical research are among the most heavily regulated activities on a global basis.


Natasha Blakeney, MPH

Latest:

Making a Difference in Cancer Trials Accrual

The integration of pre-screening all patients for eligibility in oncology studies.


CluePoints

Latest:

Case Study: Confirmation of Fraud - Diaries Completed by Staff

In a phase III trial in vascular disease, over 4,500 patients were randomized across 160 sites.


Rickie Stevens

Latest:

A Different Approach to CTMS

In order to manage critical clinical trial information, sponsors and CROs typically implement a strict data management structure...


Michael O’Kelly

Latest:

Lifecycle Modeling and Simulation in Clinical Trials

How the application of evolving M&S models are transforming full-research design strategies.


William Curatolo

Latest:

Artisanal Publishing

In my previous blog "From Science to Fiction" (ACTO, April 15, 2014), I discussed the trials and tribulations of unlearning the scientific writing style...

© 2025 MJH Life Sciences

All rights reserved.